Intro

This chapter explores the transformative approach to treating type 2 diabetes in the UK, focusing on personalized care as recommended by healthcare authorities. It highlights the role of innovative medications, such as SGLT2 inhibitors and weight loss drugs, in enhancing patient outcomes and addressing unique health needs.